The global IVD Infectious Diseases market is projected to grow from US$ 17780 million in 2024 to US$ 22230 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.8% during the forecast period.

IVD Infectious Diseases Market

In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.

Market Analysis and Insights: Global IVD Infectious Diseases Market

The US & Canada market for IVD Infectious Diseases is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for IVD Infectious Diseases is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for IVD Infectious Diseases is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of IVD Infectious Diseases include BD, BioMerieux, Abbott, Quidel, Gen-Probe, Abbott, Danaher, Sysmex and Orasure, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

IVD Infectious Diseases is widely used in various fields, such as Clinical Laboratories and Diagnostic Centers, etc. Clinical Laboratories provides greatest supports to the IVD Infectious Diseases industry development. In 2023, global % revenue of IVD Infectious Diseases went into Clinical Laboratories filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for IVD Infectious Diseases market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of IVD Infectious Diseases, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for IVD Infectious Diseases, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the IVD Infectious Diseases revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global IVD Infectious Diseases market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for IVD Infectious Diseases revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of IVD Infectious Diseases Market Report

Report Metric	Details
Report Name	IVD Infectious Diseases Market
Accounted market size in 2024	US$ 17780 million
Forecasted market size in 2030	US$ 22230 million
CAGR	3.8
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Immunochemistry Molecular Diagnostics
Segment by Application	Clinical Laboratories Diagnostic Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BD, BioMerieux, Abbott, Quidel, Gen-Probe, Danaher, Sysmex, Orasure, Hologic, Cepheid, Qiagen, Roche Diagnostics, Siemens Healthcare, Bio-Rad Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of IVD Infectious Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD Infectious Diseases companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IVD Infectious Diseases revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is IVD Infectious Diseases Market growing?

Ans: The IVD Infectious Diseases Market witnessing a CAGR of 3.8 during the forecast period 2025-2030.

What is the IVD Infectious Diseases Market size in 2030?

Ans: The IVD Infectious Diseases Market size in 2030 will be US$ 22230 million.

Who are the main players in the IVD Infectious Diseases Market report?

Ans: The main players in the IVD Infectious Diseases Market are BD, BioMerieux, Abbott, Quidel, Gen-Probe, Danaher, Sysmex, Orasure, Hologic, Cepheid, Qiagen, Roche Diagnostics, Siemens Healthcare, Bio-Rad Laboratories

What are the Application segmentation covered in the IVD Infectious Diseases Market report?

Ans: The Applications covered in the IVD Infectious Diseases Market report are Clinical Laboratories, Diagnostic Centers

What are the Type segmentation covered in the IVD Infectious Diseases Market report?

Ans: The Types covered in the IVD Infectious Diseases Market report are Immunochemistry, Molecular Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global IVD Infectious Diseases Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Immunochemistry

1.2.3 Molecular Diagnostics

1.3 Market by Application

1.3.1 Global IVD Infectious Diseases Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Clinical Laboratories

1.3.3 Diagnostic Centers

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global IVD Infectious Diseases Market Perspective (2019-2030)

2.2 Global IVD Infectious Diseases Growth Trends by Region

2.2.1 IVD Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 IVD Infectious Diseases Historic Market Size by Region (2019-2024)

2.2.3 IVD Infectious Diseases Forecasted Market Size by Region (2025-2030)

2.3 IVD Infectious Diseases Market Dynamics

2.3.1 IVD Infectious Diseases Industry Trends

2.3.2 IVD Infectious Diseases Market Drivers

2.3.3 IVD Infectious Diseases Market Challenges

2.3.4 IVD Infectious Diseases Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue IVD Infectious Diseases by Players

3.1.1 Global IVD Infectious Diseases Revenue by Players (2019-2024)

3.1.2 Global IVD Infectious Diseases Revenue Market Share by Players (2019-2024)

3.2 Global IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of IVD Infectious Diseases, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global IVD Infectious Diseases Market Concentration Ratio

3.4.1 Global IVD Infectious Diseases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Diseases Revenue in 2023

3.5 Global Key Players of IVD Infectious Diseases Head office and Area Served

3.6 Global Key Players of IVD Infectious Diseases, Product and Application

3.7 Global Key Players of IVD Infectious Diseases, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 IVD Infectious Diseases Breakdown Data by Type

4.1 Global IVD Infectious Diseases Historic Market Size by Type (2019-2024)

4.2 Global IVD Infectious Diseases Forecasted Market Size by Type (2025-2030)

5 IVD Infectious Diseases Breakdown Data by Application

5.1 Global IVD Infectious Diseases Historic Market Size by Application (2019-2024)

5.2 Global IVD Infectious Diseases Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America IVD Infectious Diseases Market Size (2019-2030)

6.2 North America IVD Infectious Diseases Market Size by Type

6.2.1 North America IVD Infectious Diseases Market Size by Type (2019-2024)

6.2.2 North America IVD Infectious Diseases Market Size by Type (2025-2030)

6.2.3 North America IVD Infectious Diseases Market Share by Type (2019-2030)

6.3 North America IVD Infectious Diseases Market Size by Application

6.3.1 North America IVD Infectious Diseases Market Size by Application (2019-2024)

6.3.2 North America IVD Infectious Diseases Market Size by Application (2025-2030)

6.3.3 North America IVD Infectious Diseases Market Share by Application (2019-2030)

6.4 North America IVD Infectious Diseases Market Size by Country

6.4.1 North America IVD Infectious Diseases Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America IVD Infectious Diseases Market Size by Country (2019-2024)

6.4.3 North America IVD Infectious Diseases Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe IVD Infectious Diseases Market Size (2019-2030)

7.2 Europe IVD Infectious Diseases Market Size by Type

7.2.1 Europe IVD Infectious Diseases Market Size by Type (2019-2024)

7.2.2 Europe IVD Infectious Diseases Market Size by Type (2025-2030)

7.2.3 Europe IVD Infectious Diseases Market Share by Type (2019-2030)

7.3 Europe IVD Infectious Diseases Market Size by Application

7.3.1 Europe IVD Infectious Diseases Market Size by Application (2019-2024)

7.3.2 Europe IVD Infectious Diseases Market Size by Application (2025-2030)

7.3.3 Europe IVD Infectious Diseases Market Share by Application (2019-2030)

7.4 Europe IVD Infectious Diseases Market Size by Country

7.4.1 Europe IVD Infectious Diseases Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe IVD Infectious Diseases Market Size by Country (2019-2024)

7.4.3 Europe IVD Infectious Diseases Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China IVD Infectious Diseases Market Size (2019-2030)

8.2 China IVD Infectious Diseases Market Size by Type

8.2.1 China IVD Infectious Diseases Market Size by Type (2019-2024)

8.2.2 China IVD Infectious Diseases Market Size by Type (2025-2030)

8.2.3 China IVD Infectious Diseases Market Share by Type (2019-2030)

8.3 China IVD Infectious Diseases Market Size by Application

8.3.1 China IVD Infectious Diseases Market Size by Application (2019-2024)

8.3.2 China IVD Infectious Diseases Market Size by Application (2025-2030)

8.3.3 China IVD Infectious Diseases Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia IVD Infectious Diseases Market Size (2019-2030)

9.2 Asia IVD Infectious Diseases Market Size by Type

9.2.1 Asia IVD Infectious Diseases Market Size by Type (2019-2024)

9.2.2 Asia IVD Infectious Diseases Market Size by Type (2025-2030)

9.2.3 Asia IVD Infectious Diseases Market Share by Type (2019-2030)

9.3 Asia IVD Infectious Diseases Market Size by Application

9.3.1 Asia IVD Infectious Diseases Market Size by Application (2019-2024)

9.3.2 Asia IVD Infectious Diseases Market Size by Application (2025-2030)

9.3.3 Asia IVD Infectious Diseases Market Share by Application (2019-2030)

9.4 Asia IVD Infectious Diseases Market Size by Region

9.4.1 Asia IVD Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia IVD Infectious Diseases Market Size by Region (2019-2024)

9.4.3 Asia IVD Infectious Diseases Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Type

10.2.1 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America IVD Infectious Diseases Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Application

10.3.1 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America IVD Infectious Diseases Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Country

10.4.1 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 BD

11.1.1 BD Company Details

11.1.2 BD Business Overview

11.1.3 BD IVD Infectious Diseases Introduction

11.1.4 BD Revenue in IVD Infectious Diseases Business (2019-2024)

11.1.5 BD Recent Developments

11.2 BioMerieux

11.2.1 BioMerieux Company Details

11.2.2 BioMerieux Business Overview

11.2.3 BioMerieux IVD Infectious Diseases Introduction

11.2.4 BioMerieux Revenue in IVD Infectious Diseases Business (2019-2024)

11.2.5 BioMerieux Recent Developments

11.3 Abbott

11.3.1 Abbott Company Details

11.3.2 Abbott Business Overview

11.3.3 Abbott IVD Infectious Diseases Introduction

11.3.4 Abbott Revenue in IVD Infectious Diseases Business (2019-2024)

11.3.5 Abbott Recent Developments

11.4 Quidel

11.4.1 Quidel Company Details

11.4.2 Quidel Business Overview

11.4.3 Quidel IVD Infectious Diseases Introduction

11.4.4 Quidel Revenue in IVD Infectious Diseases Business (2019-2024)

11.4.5 Quidel Recent Developments

11.5 Gen-Probe

11.5.1 Gen-Probe Company Details

11.5.2 Gen-Probe Business Overview

11.5.3 Gen-Probe IVD Infectious Diseases Introduction

11.5.4 Gen-Probe Revenue in IVD Infectious Diseases Business (2019-2024)

11.5.5 Gen-Probe Recent Developments

11.6 Abbott

11.6.1 Abbott Company Details

11.6.2 Abbott Business Overview

11.6.3 Abbott IVD Infectious Diseases Introduction

11.6.4 Abbott Revenue in IVD Infectious Diseases Business (2019-2024)

11.6.5 Abbott Recent Developments

11.7 Danaher

11.7.1 Danaher Company Details

11.7.2 Danaher Business Overview

11.7.3 Danaher IVD Infectious Diseases Introduction

11.7.4 Danaher Revenue in IVD Infectious Diseases Business (2019-2024)

11.7.5 Danaher Recent Developments

11.8 Sysmex

11.8.1 Sysmex Company Details

11.8.2 Sysmex Business Overview

11.8.3 Sysmex IVD Infectious Diseases Introduction

11.8.4 Sysmex Revenue in IVD Infectious Diseases Business (2019-2024)

11.8.5 Sysmex Recent Developments

11.9 Orasure

11.9.1 Orasure Company Details

11.9.2 Orasure Business Overview

11.9.3 Orasure IVD Infectious Diseases Introduction

11.9.4 Orasure Revenue in IVD Infectious Diseases Business (2019-2024)

11.9.5 Orasure Recent Developments

11.10 Hologic

11.10.1 Hologic Company Details

11.10.2 Hologic Business Overview

11.10.3 Hologic IVD Infectious Diseases Introduction

11.10.4 Hologic Revenue in IVD Infectious Diseases Business (2019-2024)

11.10.5 Hologic Recent Developments

11.11 Cepheid

11.11.1 Cepheid Company Details

11.11.2 Cepheid Business Overview

11.11.3 Cepheid IVD Infectious Diseases Introduction

11.11.4 Cepheid Revenue in IVD Infectious Diseases Business (2019-2024)

11.11.5 Cepheid Recent Developments

11.12 Qiagen

11.12.1 Qiagen Company Details

11.12.2 Qiagen Business Overview

11.12.3 Qiagen IVD Infectious Diseases Introduction

11.12.4 Qiagen Revenue in IVD Infectious Diseases Business (2019-2024)

11.12.5 Qiagen Recent Developments

11.13 Roche Diagnostics

11.13.1 Roche Diagnostics Company Details

11.13.2 Roche Diagnostics Business Overview

11.13.3 Roche Diagnostics IVD Infectious Diseases Introduction

11.13.4 Roche Diagnostics Revenue in IVD Infectious Diseases Business (2019-2024)

11.13.5 Roche Diagnostics Recent Developments

11.14 Siemens Healthcare

11.14.1 Siemens Healthcare Company Details

11.14.2 Siemens Healthcare Business Overview

11.14.3 Siemens Healthcare IVD Infectious Diseases Introduction

11.14.4 Siemens Healthcare Revenue in IVD Infectious Diseases Business (2019-2024)

11.14.5 Siemens Healthcare Recent Developments

11.15 Bio-Rad Laboratories

11.15.1 Bio-Rad Laboratories Company Details

11.15.2 Bio-Rad Laboratories Business Overview

11.15.3 Bio-Rad Laboratories IVD Infectious Diseases Introduction

11.15.4 Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2019-2024)

11.15.5 Bio-Rad Laboratories Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global IVD Infectious Diseases Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Immunochemistry

Table 3. Key Players of Molecular Diagnostics

Table 4. Global IVD Infectious Diseases Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global IVD Infectious Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global IVD Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global IVD Infectious Diseases Market Share by Region (2019-2024)

Table 8. Global IVD Infectious Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global IVD Infectious Diseases Market Share by Region (2025-2030)

Table 10. IVD Infectious Diseases Market Trends

Table 11. IVD Infectious Diseases Market Drivers

Table 12. IVD Infectious Diseases Market Challenges

Table 13. IVD Infectious Diseases Market Restraints

Table 14. Global IVD Infectious Diseases Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global IVD Infectious Diseases Revenue Share by Players (2019-2024)

Table 16. Global Top IVD Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2023)

Table 17. Global IVD Infectious Diseases Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by IVD Infectious Diseases Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of IVD Infectious Diseases, Headquarters and Area Served

Table 20. Global Key Players of IVD Infectious Diseases, Product and Application

Table 21. Global Key Players of IVD Infectious Diseases, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global IVD Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global IVD Infectious Diseases Revenue Market Share by Type (2019-2024)

Table 25. Global IVD Infectious Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global IVD Infectious Diseases Revenue Market Share by Type (2025-2030)

Table 27. Global IVD Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global IVD Infectious Diseases Revenue Share by Application (2019-2024)

Table 29. Global IVD Infectious Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global IVD Infectious Diseases Revenue Share by Application (2025-2030)

Table 31. North America IVD Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America IVD Infectious Diseases Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America IVD Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America IVD Infectious Diseases Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America IVD Infectious Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America IVD Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America IVD Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe IVD Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe IVD Infectious Diseases Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe IVD Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe IVD Infectious Diseases Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe IVD Infectious Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe IVD Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe IVD Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)

Table 45. China IVD Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 46. China IVD Infectious Diseases Market Size by Type (2025-2030) & (US$ Million)

Table 47. China IVD Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 48. China IVD Infectious Diseases Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia IVD Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia IVD Infectious Diseases Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia IVD Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia IVD Infectious Diseases Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia IVD Infectious Diseases Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia IVD Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia IVD Infectious Diseases Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America IVD Infectious Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)

Table 63. BD Company Details

Table 64. BD Business Overview

Table 65. BD IVD Infectious Diseases Product

Table 66. BD Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 67. BD Recent Developments

Table 68. BioMerieux Company Details

Table 69. BioMerieux Business Overview

Table 70. BioMerieux IVD Infectious Diseases Product

Table 71. BioMerieux Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 72. BioMerieux Recent Developments

Table 73. Abbott Company Details

Table 74. Abbott Business Overview

Table 75. Abbott IVD Infectious Diseases Product

Table 76. Abbott Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 77. Abbott Recent Developments

Table 78. Quidel Company Details

Table 79. Quidel Business Overview

Table 80. Quidel IVD Infectious Diseases Product

Table 81. Quidel Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 82. Quidel Recent Developments

Table 83. Gen-Probe Company Details

Table 84. Gen-Probe Business Overview

Table 85. Gen-Probe IVD Infectious Diseases Product

Table 86. Gen-Probe Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 87. Gen-Probe Recent Developments

Table 88. Abbott Company Details

Table 89. Abbott Business Overview

Table 90. Abbott IVD Infectious Diseases Product

Table 91. Abbott Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 92. Abbott Recent Developments

Table 93. Danaher Company Details

Table 94. Danaher Business Overview

Table 95. Danaher IVD Infectious Diseases Product

Table 96. Danaher Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 97. Danaher Recent Developments

Table 98. Sysmex Company Details

Table 99. Sysmex Business Overview

Table 100. Sysmex IVD Infectious Diseases Product

Table 101. Sysmex Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 102. Sysmex Recent Developments

Table 103. Orasure Company Details

Table 104. Orasure Business Overview

Table 105. Orasure IVD Infectious Diseases Product

Table 106. Orasure Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 107. Orasure Recent Developments

Table 108. Hologic Company Details

Table 109. Hologic Business Overview

Table 110. Hologic IVD Infectious Diseases Product

Table 111. Hologic Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 112. Hologic Recent Developments

Table 113. Cepheid Company Details

Table 114. Cepheid Business Overview

Table 115. Cepheid IVD Infectious Diseases Product

Table 116. Cepheid Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 117. Cepheid Recent Developments

Table 118. Qiagen Company Details

Table 119. Qiagen Business Overview

Table 120. Qiagen IVD Infectious Diseases Product

Table 121. Qiagen Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 122. Qiagen Recent Developments

Table 123. Roche Diagnostics Company Details

Table 124. Roche Diagnostics Business Overview

Table 125. Roche Diagnostics IVD Infectious Diseases Product

Table 126. Roche Diagnostics Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 127. Roche Diagnostics Recent Developments

Table 128. Siemens Healthcare Company Details

Table 129. Siemens Healthcare Business Overview

Table 130. Siemens Healthcare IVD Infectious Diseases Product

Table 131. Siemens Healthcare Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 132. Siemens Healthcare Recent Developments

Table 133. Bio-Rad Laboratories Company Details

Table 134. Bio-Rad Laboratories Business Overview

Table 135. Bio-Rad Laboratories IVD Infectious Diseases Product

Table 136. Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 137. Bio-Rad Laboratories Recent Developments

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Global IVD Infectious Diseases Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global IVD Infectious Diseases Market Share by Type: 2023 VS 2030

Figure 3. Immunochemistry Features

Figure 4. Molecular Diagnostics Features

Figure 5. Global IVD Infectious Diseases Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global IVD Infectious Diseases Market Share by Application: 2023 VS 2030

Figure 7. Clinical Laboratories Case Studies

Figure 8. Diagnostic Centers Case Studies

Figure 9. IVD Infectious Diseases Report Years Considered

Figure 10. Global IVD Infectious Diseases Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global IVD Infectious Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global IVD Infectious Diseases Market Share by Region: 2023 VS 2030

Figure 13. Global IVD Infectious Diseases Market Share by Players in 2023

Figure 14. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by IVD Infectious Diseases Revenue in 2023

Figure 16. North America IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America IVD Infectious Diseases Market Share by Type (2019-2030)

Figure 18. North America IVD Infectious Diseases Market Share by Application (2019-2030)

Figure 19. North America IVD Infectious Diseases Market Share by Country (2019-2030)

Figure 20. United States IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe IVD Infectious Diseases Market Size YoY (2019-2030) & (US$ Million)

Figure 23. Europe IVD Infectious Diseases Market Share by Type (2019-2030)

Figure 24. Europe IVD Infectious Diseases Market Share by Application (2019-2030)

Figure 25. Europe IVD Infectious Diseases Market Share by Country (2019-2030)

Figure 26. Germany IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. China IVD Infectious Diseases Market Size YoY (2019-2030) & (US$ Million)

Figure 33. China IVD Infectious Diseases Market Share by Type (2019-2030)

Figure 34. China IVD Infectious Diseases Market Share by Application (2019-2030)

Figure 35. Asia IVD Infectious Diseases Market Size YoY (2019-2030) & (US$ Million)

Figure 36. Asia IVD Infectious Diseases Market Share by Type (2019-2030)

Figure 37. Asia IVD Infectious Diseases Market Share by Application (2019-2030)

Figure 38. Asia IVD Infectious Diseases Market Share by Region (2019-2030)

Figure 39. Japan IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. China Taiwan IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Southeast Asia IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. India IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Australia IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size YoY (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America IVD Infectious Diseases Market Share by Type (2019-2030)

Figure 47. Middle East, Africa, and Latin America IVD Infectious Diseases Market Share by Application (2019-2030)

Figure 48. Middle East, Africa, and Latin America IVD Infectious Diseases Market Share by Country (2019-2030)

Figure 49. Brazil IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Mexico IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Turkey IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Israel IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. GCC Countries IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. BD Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 56. BioMerieux Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 57. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 58. Quidel Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 59. Gen-Probe Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 60. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 61. Danaher Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 62. Sysmex Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 63. Orasure Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 64. Hologic Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 65. Cepheid Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 66. Qiagen Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 67. Roche Diagnostics Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 68. Siemens Healthcare Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 69. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions